TAKAYASU ARTERITIS
Clinical trials for TAKAYASU ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new TAKAYASU ARTERITIS trials appear
Sign up with your email to follow new studies for TAKAYASU ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a dengue vaccine protect those with autoimmune conditions?
⭐️ VACCINE ⭐️ Recruiting nowThis study is testing a live attenuated dengue vaccine (Butantan-DV) in 477 people aged 12–59 with stable autoimmune rheumatic diseases (like rheumatoid arthritis or lupus) and in healthy volunteers. The goal is to see if the vaccine is safe and produces a strong immune response …
Matched conditions: TAKAYASU ARTERITIS
Phase: PHASE4 • Sponsor: University of Sao Paulo General Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 29, 2026 08:03 UTC
-
What's it like living with takayasu arteritis? new study asks patients and doctors
Knowledge-focused Recruiting nowThis study uses two questionnaires to learn about the experiences of people with Takayasu arteritis (TAK) and how doctors manage the condition. About 50 patients and an unspecified number of physicians will share their views on symptoms, treatment priorities, and unmet needs. The…
Matched conditions: TAKAYASU ARTERITIS
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Apr 29, 2026 08:03 UTC